Facing a PR crisis and the loss of major government contracts for its main anthrax vaccine, Emergent, a biopharmaceutical group, was in a battle for survival. The CEO turned to TM to help position its brand, repair its damaged reputation and prepare for an IPO.
  • Work undertaken:
  • Brand positioning
  • Message platform
  • Brand architecture
  • Naming
  • Visual identity
  • Website
  • Brand implementation
  • Collateral development
  • Signage
  • Brand training
New York London